About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.
External link for Worldwide Clinical Trials
What a fantastic way to enjoy the holiday season! 🎉 Our teams from around the globe have been getting together to celebrate the holidays! Here are some pictures from a recent celebration at our headquarters in Research Triangle Park, NC. It's always wonderful to take a moment to connect, reflect, and celebrate the amazing work we’re doing together to help advance life-changing medications.
Say hello to Juliane Mills and Aman Khera EMBA FRAPS FTOPRA Khera at the 38th Annual Family and Scientific Conference hosted by the National MPS Society in Orlando, FL! At this conference, they will be conducting a survey to find out how to best support patients and families in clinical research. We look forward to hearing the results!
We’re pleased to announce Jason Meggs has joined Worldwide as our new Chief Financial Officer! Bringing 25+ years of leadership experience and financial acumen, Jason will oversee Worldwide’s financial and legal strategy to help us drive operational efficiency and deliver high-quality results. https://ow.ly/xj3X50Usxm4
How have decentralized clinical trials (DCTs) evolved beyond a "one-size-fits-all" solution? In a recent conversation with Applied Clinical Trials Magazine, Scott Palmese shares common misconceptions about DCTs and his perspective on how they will transform the 2025 clinical landscape. Check out Scott’s insights in the full article today: https://lnkd.in/eR2eGP3E
Scott Palmese, executive director, site relationships and DCT solutions, Worldwide Clinical Trials, discusses the practice of incorporating decentralized elements in a study rather than planning a decentralized trial from the start.
What fantastic insights on the future of CAR T development from Amy Raymond, PhD, PMP! Watch the full webinar on-demand today featuring Nathan Chadwick, Simran Padam, MD, APMMC, Tahseen Mozaffar, & Chris Jenkins: https://ow.ly/xBsy50UlXut
Today, on International Day of Persons with Disabilities, we honor all people with disabilities – both visible and invisible. At Worldwide, we support individuals and team members with disabilities through partnership, advocacy, and inclusion. Together, we can build a future where equity and accessibility are the norm.
Are you attending Clinical Trials in Oncology Europe today? Don't miss the opportunity to meet our team of experts at Booth 18!
Driving exponential business growth through innovative solutions and dynamic client relationships
There’s some great insights at Clinical Trials in Oncology Europe including our own Matt Cooper Worldwide Clinical Trials. Drop by booth 18 and we would be delighted to discuss your clinical plans. #OncologyEurope
Thank you for sharing, Joy Clark! We appreciate all that you do for health equity at Worldwide.
The greatest gift you can give your employees is a healthy life, Joy Clark passionately reminded us at our Health Equity in the Workforce summit in Raleigh, North Carolina. #HealthEquity #WellbeingWorksBetter
When faced with managing a schizophrenia clinical trial, how do you manage the challenge of patient retention? Find out some of the best ways to prevent and reduce participant dropout in schizophrenia studies in our checklist: https://ow.ly/neXO50Ugmy1
At Worldwide, we know firsthand the challenges that come with running complex hematology-oncology clinical trials, and we’re here to support you across every phase of development. As we work towards better treatments, we’d love to connect with you! Stop by Booth 3105 at the 66th ASH Annual Meeting to meet our experts and explore how we can help support your hematology-oncology study! https://ow.ly/mw0T50Ugbhp